Sirna Therapeutics, Galapagos, Asinex, Invitrogen, Caltag Laboratories, Qiagenn, Procognia | GenomeWeb

Sirna Restructuring Detailed in SEC Filing;
Company Lays Off Eleven

Sirna Therapeutics said this week in a filing with the US Securities and Exchange Commission that its previously announced layoffs included the termination of 11 employees.

According to the company, the layoffs resulted in an annualized salary and benefits savings of $2.1 million. Severance and other costs related to the reduction in force will be $350,000, Sirna noted in the filing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.